News 2018

January 2018

Tina's work demonstrating the effectiveness of ex vivo-expanded NK cells derived from peripheral blood or ascites fluid of ovarian cancer patients against primary tumour is published in Cancer Immunology, Immunotherapy:

Ex vivo-expanded NK cells from blood and ascites of ovarian cancer patients are cytotoxic against autologous primary ovarian cancer cells.

Nham T, Poznanski SM, Fan IY, Shenouda MM, Chew MV, Lee AJ, Vahedi F, Karimi Y, Butcher M, Lee DA, Hirte H, Ashkar AA.

Cancer Immunol Immunother. 2018 Jan 3. [Epub ahead of print]